Found: 23
Select item for more details and to access through your institution.
REKOMENDACJE LECZENIA WIRUSOWYCH ZAPALEŃ WĄTROBY TYPU C POLSKIEJ GRUPY EKSPERTÓW HCV 2015.
- Published in:
- Forum Zakażeń, 2015, v. 6, n. 3, p. 149
- By:
- Publication type:
- Article
Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting.
- Published in:
- Archives of Medical Science, 2022, v. 18, n. 6, p. 1460, doi. 10.5114/aoms.2019.86569
- By:
- Publication type:
- Article
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
- Published in:
- Liver International, 2011, v. 31, p. 30, doi. 10.1111/j.1478-3231.2011.02539.x
- By:
- Publication type:
- Article
Depressive symptoms and cognitive dysfunction in patients with hepatitis C treated with interferon-α and ribavirine.
- Published in:
- Archives of Psychiatry & Psychotherapy, 2008, v. 10, n. 1, p. 85
- By:
- Publication type:
- Article
The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130899
- By:
- Publication type:
- Article
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5193, doi. 10.3390/jcm11175193
- By:
- Publication type:
- Article
HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 2, p. 379, doi. 10.3390/jcm11020379
- By:
- Publication type:
- Article
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3280, doi. 10.3390/jcm10153280
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1789, doi. 10.1111/liv.14858
- By:
- Publication type:
- Article
Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1944, doi. 10.1111/jgh.15337
- By:
- Publication type:
- Article
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020.
- Published in:
- Clinical & Experimental Hepatology, 2020, v. 6, n. 3, p. 163, doi. 10.5114/ceh.2020.98606
- By:
- Publication type:
- Article
Searching for the optimal population for hepatitis C virus screening in Poland.
- Published in:
- Clinical & Experimental Hepatology, 2020, v. 6, n. 2, p. 74, doi. 10.5114/ceh.2020.94969
- By:
- Publication type:
- Article
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD).
- Published in:
- Clinical & Experimental Hepatology, 2018, v. 4, n. 3, p. 153, doi. 10.5114/ceh.2018.78118
- By:
- Publication type:
- Article
Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study.
- Published in:
- Annals of Gastroenterology, 2021, v. 34, n. 3, p. 438, doi. 10.20524/aog.2021.0595
- By:
- Publication type:
- Article
Continuous up to 4 Years Entecavir Treatment of HBV-Infected Adolescents – A Longitudinal Study in Real Life.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163691
- By:
- Publication type:
- Article
Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 11, p. 1, doi. 10.5812/hepatmon.13678
- By:
- Publication type:
- Article
Hematological Adverse Events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection.
- Published in:
- Hepatitis Monthly, 2011, v. 11, n. 12, p. 968, doi. 10.5812/kowsar.1735143X.789
- By:
- Publication type:
- Article
Interferon-induced thyroiditis during treatment of chronic hepatitis C.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2012, v. 63, n. 1, p. 66
- By:
- Publication type:
- Article
Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2012, v. 63, n. 1, p. 52
- By:
- Publication type:
- Article
Efficacy of pegylated interferon α-2b and ribavirin in chronic hepatitis C virus (genotypes 1 and 4) infection.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience.
- Published in:
- Hepatitis Monthly, 2018, v. 18, n. 8, p. 1, doi. 10.5812/hepatmon.80761
- By:
- Publication type:
- Article
STEATOS IS INFLUENCES HEPATOCYTES PROLIFERATIVE POTENTIAL IN CHRONIC HEPATITIS C PATIENTS.
- Published in:
- Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 2018, v. 69, n. 4, p. 388, doi. 10.5114/pjp.2018.78517
- By:
- Publication type:
- Article
Real‐world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 7, p. 1238, doi. 10.1111/jgh.14936
- By:
- Publication type:
- Article